OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

Published by: GBI Research

Published: Nov. 30, 2012 - 104 Pages


Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview
3.1 Overview
3.2 OTC Pharmaceuticals
3.3 Rx-to-OTC Switching
3.4 Regulation of OTC Pharmaceuticals
3.4.1 China
3.4.2 India
3.4.3 Russia
3.4.4 Brazil
3.4.5 Mexico
3.4.6 Turkey
3.4.7 Indonesia
4 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Product Types
4.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Overview
4.2 Leading Product Types
4.2.1 Cough, Cold and Allergy
4.2.2 Analgesics/Antipyretics
4.2.3 Gastrointestinal
4.2.4 Dermatologicals
4.2.5 Vitamins, Minerals and Supplements
4.2.6 Lifestyle OTC Products
5 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Comparison
5.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, 2011-2018
5.2 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Market Drivers and Restraints
5.3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, Forecast Methodology
6 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Geographical Breakdown
6.1 China
6.1.1 Introduction
6.1.2 OTC Category Analysis
6.1.3 Key Growth Drivers and Restraints
6.1.4 OTC Sales Forecast to 2018
6.1.5 Recent Developments
6.1.6 Outlook
6.2 India
6.2.1 Introduction
6.2.2 OTC Category Analysis
6.2.3 Key Growth Drivers and Restraints
6.2.4 OTC Sales Forecast to 2018
6.2.5 Recent Developments
6.2.6 Outlook
6.3 Russia
6.3.1 Introduction
6.3.2 OTC Category Analysis
6.3.3 Key Growth Drivers and Restraints
6.3.4 OTC Sales Forecast to 2018
6.3.5 Recent Developments
6.3.6 Outlook
6.4 Brazil
6.4.1 Introduction
6.4.2 OTC Category Analysis
6.4.3 Key Growth Drivers and Restraints
6.4.4 OTC Sales Forecast to 2018
6.4.5 Recent Developments
6.4.6 Outlook
6.5 Mexico
6.5.1 Introduction
6.5.2 OTC Category Analysis
6.5.3 Key Growth Drivers and Restraints
6.5.4 OTC Sales Forecast to 2018
6.5.5 Recent Developments
6.5.6 Outlook
6.6 Turkey
6.6.1 Introduction
6.6.2 OTC Category Analysis
6.6.3 Key Growth Drivers and Restraints
6.6.4 OTC Sales Forecast to 2018
6.6.5 Recent Developments
6.6.6 Outlook
6.7 Indonesia
6.7.1 Introduction
6.7.2 OTC Category Analysis
6.7.3 Key Growth Drivers and Restraints
6.7.4 OTC Sales Forecast to 2018
6.7.5 Recent Developments
6.7.6 Outlook
7 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Takeaway
8 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Appendix
8.1 Abbreviations
8.2 Sources
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Primary Research
8.3.4 Therapeutic Landscape
8.3.5 Expert Panel Validation
8.4 Contact Us
8.5 Disclaimer
1.1 List of Tables
Table 1: OTC Market, Seven Emerging Markets, Sales ($bn), 2011-2018
Table 2: OTC Market, Seven Emerging Markets, Drivers and Restraints
Table 3: OTC Market, Drivers and Restraints, China
Table 4: OTC Market, China, Sales ($bn), 2011-2018
Table 5: OTC Market, Drivers and Restraints, India
Table 6: OTC Market, India, Sales ($bn), 2011-2018
Table 7: OTC Market, Drivers and Restraints, Russia
Table 8: OTC Market, Russia, Sales ($bn), 2011-2018
Table 9: OTC Market, Drivers and Restraints, Brazil
Table 10: OTC Market, Brazil, Sales ($bn), 2011-2018
Table 11: OTC Market, Drivers and Restraints, Mexico
Table 12: OTC Market, Mexico, Sales ($bn), 2011-2018
Table 13: OTC Market, Drivers and Restraints, Turkey
Table 14: OTC Market, Turkey, Sales ($bn), 2011-2018
Table 15: OTC Market, Drivers and Restraints, Indonesia
Table 16: OTC Market, Indonesia, Sales ($bn), 2011-2018
1.2 List of Figures
Figure 1: OTC Market, Seven Emerging Markets, Sales by Markets ($bn), 2011-2018
Figure 2: OTC Market, Seven Emerging Markets, Annual Growth Rates (%), 2011-2018
Figure 3: Population Pyramid by Age Class, China, 2010
Figure 4: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 5: Main Causes of Death, China, Ages 0-14, Both Sexes (%), 2008
Figure 6: Main Causes of Death, China, Ages 15-59, Both Sexes (%), 2008
Figure 7: Main Causes of Death, China, Ages >60, Both Sexes (%), 2008
Figure 8: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 9: OTC Market, China, by Category (Including TCM), Sales (%), 2011
Figure 10: OTC Market, China, by Category (Excluding TCM), Sales (%), 2011
Figure 11: OTC Market, China, Sales ($bn), 2011-2018
Figure 12: Population Pyramid, India, 2010
Figure 13: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 14: Main Causes of Death, India, Ages 0-14, Both Sexes (%), 2008
Figure 15: Main Causes of Death, India, Ages 15-59, Both Sexes (%), 2008
Figure 16: Main Causes of Death, India, Ages >60, Both Sexes (%), 2008
Figure 17: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 18: OTC Market, India, by Category, Sales (%),2011
Figure 19: OTC Market, India, Sales ($bn), 2011-2018
Figure 20: Population Pyramid, Russia, 2010
Figure 21: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 22: Main Causes of Death, Russia, Ages 0-14, Both Sexes (%), 2008
Figure 23: Main Causes of Death, Russia, Ages 15-59, Both Sexes (%), 2008
Figure 24: Main Causes of Death, Russia, Age >60, Both Sexes (%), 2008
Figure 25: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 26: OTC Market, Russia, by Category, Sales (%), 2011
Figure 27: OTC Market, Russia, Sales ($bn), 2011-2018
Figure 28: Population Pyramid, Brazil, 2010
Figure 29: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 30: Main Causes of Death, Brazil, Ages 0-14, Both Sexes (%), 2008
Figure 31: Main Causes of Death, Brazil, Ages 15-59, Both Sexes (%), 2008
Figure 32: Main Causes of Death, Brazil, Ages >60, Both Sexes (%), 2008
Figure 33: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 34: OTC Market, Brazil, by Category, Sales (%), 2011
Figure 35: OTC Market, Brazil, Sales ($bn), 2011-2018
Figure 36: Population Pyramid, Mexico, 2010
Figure 37: Populations > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 38: Main Causes of Death, Mexico, Ages 0-14, Both Sexes (%), 2008
Figure 39: Main Causes of Death, Mexico, Ages 15-59, Both Sexes (%), 2008
Figure 40: Main Causes of Death, Mexico, Ages >60, Both Sexes (%), 2008
Figure 41: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 42: OTC Market, Mexico, by Category, Sales (%), 2011
Figure 43: OTC Market, Mexico, Sales ($bn), 2011-2018
Figure 44: Population Pyramid, Turkey, 2010
Figure 45: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 46: Main Causes of Death, Turkey, Ages 0-14, Both Sexes (%), 2008
Figure 47: Main Causes of Death, Turkey, Ages 15-59, Both Sexes (%), 2008
Figure 48: Main Causes of Death, Turkey, Ages >60, Both Sexes (%), 2008
Figure 49: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 50: OTC Market, Turkey, by Category, Sales (%), 2011
Figure 51: OTC Market, Turkey, Sales ($bn), 2011-2018
Figure 52: Population Pyramid, Indonesia, 2010
Figure 53: Population > 60 Years, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 54: Main Causes of Death, Indonesia, Ages 0-14, Both Sexes (%), 2008
Figure 55: Main Causes of Death, Indonesia, Ages 15-59, Both Sexes (%), 2008
Figure 56: Main Causes of Death, Indonesia, Ages >60, Both Sexes (%), 2008
Figure 57: Overweight and Obese Population, Seven Emerging Markets, CAGR (%), 2012-2018
Figure 58: OTC Market, Indonesia, by Category (Including TCM), Sales (%), 2011
Figure 59: OTC Market, Indonesia, by Category (Excluding TCM), Sales (%), 2011
Figure 60: OTC Market, Indonesia, Sales ($bn), 2011-2018
Figure 61: GBI Research Market Forecasting Model

Abstract

OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

Summary

GBI Research, the leading business intelligence provider, has released its latest research, “OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.

Six main product categories are covered in the report -
  • Cough, cold and allergy treatments
  • Analgesics and antipyretics
  • Gastrointestinal remedies
  • Dermatological products
  • Vitamins, minerals and supplements
  • Lifestyle OTC products
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

All seven markets are expected to continue growth trends over the period 2011–2018, with China as the fastest growing market with a CAGR of 10%. Consumers within these markets are increasing in affluence and are becoming more informed in terms of health education matters. This has lead to an increase in self-care and in purchases of OTC pharmaceuticals.

The populations of all seven markets are becoming more elderly as healthcare systems and general living conditions are improving, this is a significant driver for the OTC market as the over 60s use the most OTC products, worldwide, of any age group. Obesity is also increasing within these markets, particularly in China. This will drive the growth of the overall OTC market and will act as a specific driver for weight management products that fall under the lifestyle OTC category.

Scope
  • The report analyzes trends in population health, healthcare and self-care and uses these trends to inform the future buying habits of the OTC market.
  • Current and future trends of major health issues affecting populations within the markets.
  • Market forecasts for OTC products for each country.
  • OTC market segmentation by six product categories.
  • Information on the local regulatory systems of each country.
Reasons to buy
  • Understand how the OTC market has developed and is continuing to develop within the featured markets.
  • Predict which products are likely to be most successful in the future.
  • Gain an understanding of the possible market available for specific products.
  • Understand how new products can gain OTC status in the featured markets.


Get full details about this report >>
 
Learn more about this product


Price and delivery options
Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.